Key facts
- This page summarizes Eric H. L. So's Form 4 filing for Helus Pharma Inc. (HELP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2026, 21:16.
Eric H. L. So - 30 Sep 2026 Form 4 Insider Report for Helus Pharma Inc. (HELP)
- Reporting relationship
- Director
- Issuer ticker
- HELP
- Reported as of
- 30 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2026, 21:16:58 UTC
- Prior SEC filing
- 11 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric H. L. So
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric H. L. So filed Form 4 for Helus Pharma Inc. (HELP) on 01 Oct 2026.
Change
- Previous filing in this sequence was filed on 11 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002116526
Primary reporting owner
So Eric H. L.
- Relationship
- Director
- Address
- C/O HELUS PHARMA INC., 100 KING STREET W., SUITE 5600, TORONTO, ONTARIO, CANADA
- Signature
- /s/ Eric H. L. So
- Signature date
- 01 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HELP
transaction
Common Shares
Award
- Transaction value
- Shares
- +248,000
- Change %
- +5.6%
- Price
- Shares after
- 4,713,014
- Date
- 30 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2
HELP
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 53,616
- Date
- 30 Sep 2026
- Ownership
- Held by spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting.
Footnote F2
Each RSU represents a right to receive one share of the Issuer's common stock.